BioCentury
ARTICLE | Company News

Flagship merges microbiome companies Evelo, Epiva

July 13, 2016 12:47 AM UTC

Flagship Ventures merged its portfolio companies Evelo Biosciences Inc. (Cambridge, Mass.) and Epiva Biosciences (Cambridge, Mass.). The merged entity will develop microbiome therapeutics that interact with the immune system to treat a range of diseases. Evelo was pursuing microbiome therapies for cancer, and Epiva was developing microbiome therapies for autoimmune and inflammatory diseases. ...